In: International Immunology, 2017, vol. 30, no. 3, p. 103-111
|
In: International Journal of Public Health, 2015, vol. 60, no. 7, p. 767-780
|
In: Transactions of The Royal Society of Tropical Medicine and Hygiene, 2017, vol. 111, no. 10, p. 457-463
|
In: Transactions of The Royal Society of Tropical Medicine and Hygiene, 2017, vol. 111, no. 1, p. 12-17
|
In: Journal of clinical medicine, 2020, vol. 9, no. 2, p. 15 p
Novel strategies are needed to address vaccine hesitancy (VH), which correlates with complementary and alternative medicine (CAM). In Switzerland, CAM providers play important roles in vaccine counseling of vaccine hesitant (VH) parents, and traditional vaccination messaging tends to overlook CAM provider perspectives. In the setting of a Swiss national research program on VH, our key strategy ...
|
In: Plos one, 2012, vol. 7, no. 4, p. e35485
Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1...
|
In: EcoHealth, 2014, vol. 11, no. 3, p. 356-371
|
In: Current Infectious Disease Reports, 2014, vol. 16, no. 9, p. 1-11
|
In: Clinical Microbiology Reviews, 2019, vol. 32, no. 2, p. e00084-18
There is substantial variation between individuals in the immune response to vaccination. In this review, we provide an overview of the plethora of studies that have investigated factors that influence humoral and cellular vaccine responses in humans. These include intrinsic host factors (such as age, sex, genetics, and comorbidities), perinatal factors (such as gestational age, birth weight,...
|
In: The Journal of clinical investigation, 2010, vol. 120, no. 5, p. 1663-1673
The target of neutralizing antibodies that protect against influenza virus infection is the viral protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses into subtypes (H1–H16). The neutralizing antibody response to influenza virus is thought to be specific for a few antigenically related isolates within a given subtype. However, while heterosubtypic...
|